Pacific Biosciences of California (PACB) — Cash Flow Reinvestment Rate
Pacific Biosciences of California (PACB) has a Cash Flow Reinvestment Rate of 0.72x as of March 2020, reinvesting $54.33 Million (capex $117.00K plus investments $-54.21 Million) from operating cash flow of $75.36 Million. Check PACB cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Pacific Biosciences of California Cash Flow Reinvestment Rate (2020–2020)
Historical reinvestment intensity for Pacific Biosciences of California across 1 annual periods. Explore Pacific Biosciences of California debt service capacity to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Pacific Biosciences of California (2020–2020)
Year-by-year capital reinvestment analysis for Pacific Biosciences of California. For live market cap and broader valuation context, see how much is Pacific Biosciences of California worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 11.25x | $219.32 Million | $19.50 Million | $1.04 Million | — |